Cu-Catalyzed Conjugate Addition of Grignard Reagents to Thiochromones: An Enantioselective Pathway for Accessing 2-Alkylthiochromanones

Shihui Luo; Ling Meng; Qingxiong Yang; Jun Wang

doi:10.1055/s-0037-1610225

Synlett, Table of Contents

Synlett 2018; 29(15): 2071-2075
DOI: 10.1055/s-0037-1610225

letter

Cu-Catalyzed Conjugate Addition of Grignard Reagents to Thiochromones: An Enantioselective Pathway for Accessing 2-Alkylthiochromanones

Authors

Shihui Luo

^aDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, P. R. of China Email: wang.j@sustc.edu.cn
Ling Meng

^aDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, P. R. of China Email: wang.j@sustc.edu.cn
Qingxiong Yang*

^bSchool of Karst Science, Guizhou Normal University/State Engineering Technology Institute for Karst Desertification Control, Guiyang 550001, P. R. of China Email: yangqx@gznu.edu.cn
Jun Wang*

^aDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, P. R. of China Email: wang.j@sustc.edu.cn

Abstract

All articles of this category

Abstract

The enantioselective incorporation of alkyl groups in thiochromones was realized for the first time by a Cu/(R,S)-PPF-P ^t Bu₂-catalyzed conjugate addition of Grignard reagents to thiochromones. With this method, a series of 2-methylthiochromanones were obtained in good yields (up to 96% yield) with moderate-to-good ee values (up to 87% ee). The established method expedites the synthesis of a large library of chiral thiochromanones for further synthetic applications and biological studies.

Key words

asymmetric synthesis - Grignard reagents - conjugate addition - thiochromanones - flavonoids

Full Text

References

References and Notes

1a The Flavonoids: Advances in Research Since 1980 . Harborne JB. Chapman and Hall; New York: 1988
1b Harborne JB. Williams CA. Nat. Prod. Rep. 1995; 12: 639
1c Le Bail JC. Varnat F. Nicolas JC. Habrioux G. Cancer Lett. 1998; 130: 209
1d Bracke ME. Depypere HT. Boterberg T. Van Marck VL. Vennekens KM. Vanluchene E. Nuytinck M. Serreyn R. Mareel MM. J. Natl. Cancer Inst. 1999; 91: 354
1e Pietta PG. J. Nat. Prod. 2000; 63: 1035
1f Chang LC. Kinghorn AD. In Bioactive Compounds from Natural Sources: Isolation, Characterisation and Biological Properties . Tringali C. Taylor & Francis; London: 2001
1g Flavonoids: Chemistry, Biochemistry and Applications . Andersen ØM. Markham KR. Taylor & Francis; London: 2006

2a Picker K. Ritchie E. Taylor WC. Aust. J. Chem. 1976; 29: 2023
2b Kawasaki M. Yoshikai H. Kakuda H. Toyooka N. Tanaka A. Goto M. Kometani T. Heterocycles 2006; 68: 483
2c Albrecht U. Lalk M. Langer P. Bioorg. Med. Chem. 2005; 13: 1531
2d Krohn K. Michel A. Bahramsari R. Flörke U. Aust HJ. Draeger S. Schulz B. Wray V. Nat. Prod. Lett. 1996; 8: 43
2e Emami S. Banipoulad T. Irannejad H. Foroumadi A. Falahati M. Ashrafi-Khozani M. Sharifynia S. J. Enz. Inhib. Med. Chem. 2014; 29: 263
2f Feng L. Maddox MM. Alam MZ. Tsutsumi LS. Narula G. Bruhn DF. Wu X. Sandhaus S. Lee RB. Simmons CJ. Tse-Dinh Y.-C. Hurdle JG. Lee RE. Sun D. J. Med. Chem. 2014; 57: 8398
2g Seifert T. Malo M. Kokkola T. Engen K. Fridén-Saxin M. Wallén EA. A. Lahtela-Kakkonen M. Jarho EM. Luthman K. J. Med. Chem. 2014; 57: 9870

3a Schneller SW. Thiochromanones and Related Compounds . In Advances in Heterocyclic Chemistry . Vol. 18. Katritzky AR. Boulton AJ. Academic Press; New York: 1975
3b Ramalingam K. Thyvelikakath GX. Berlin KD. Chesnut RW. Brown RA. Durham NN. Ealick SE. Van der Helm D. J. Med. Chem. 1977; 20: 847
3c Philipp A. Jirkovsky I. Martel RR. J. Med. Chem. 1980; 23: 1372
3d Holshouser MH. Loeffler LJ. Hall IH. J. Med. Chem. 1981; 24: 853
3e Wang HK. Bastow KF. Cosentino LM. Lee KH. J. Med. Chem. 1996; 39: 1975
3f Dhanak D. Keenan RM. Burton G. Kaura A. Darcy MG. Shah DH. Ridgers LH. Breen A. Lavery P. Tew DG. West A. Bioorg. Med. Chem. Lett. 1998; 8: 3677
3g Nussbaumer P. Lehr P. Billich A. J. Med. Chem. 2002; 45: 4310
3h Soni DV. Jacobberger JW. Cell Cycle 2004; 3: 349
3i Kataoka T. Watanabe S. Mori E. Kadomoto R. Tanimura S. Kohno M. Bioorg. Med. Chem. 2004; 12: 2397

4a Goldfarb DS. US Patent 20090163545, 2014
4b Guo C. Fang L. Liu Y. Su X. Li C. Sun L. Luo W. Liang L. Huang Y. CN Patent 101434595B, 2014

5 Hoettecke N. Rotzoll S. Albrecht U. Lalk M. Fischer C. Langer P. Bioorg. Med. Chem. 2008; 16: 10319
6 Choi EJ. Lee JI. Kim GH. Int. J. Mol. Med. 2012; 29: 252

7a Sangeetha S. Muthupandi P. Sekar G. Org. Lett. 2015; 17: 6006
7b Bouisseau A. Glancy J. Willis MC. Org. Lett. 2016; 18: 5676
7c Vaghoo H. Prakash GK. Narayanan A. Choudhary R. Paknia F. Mathew T. Olah GA. Org. Lett. 2015; 17: 6170
7d Palani T. Park K. Song KH. Lee S. Adv. Synth. Catal. 2013; 355: 1160
7e Ali A. Ahmad VU. Liebscher J. Eur. J. Org. Chem. 2001; 529

8a Kaye PT. Mphahlele MJ. Synth. Commun. 1995; 25: 1495
8b Cui D-M. Kawamura M. Shimada S. Hayashi T. Tanaka M. Tetrahedron Lett. 2003; 44: 4007

9a Kumar P. Rao AT. Pandey B. Synth. Commun. 1994; 24: 3297
9b Lemke MK. Schwab P. Fischer P. Tischer S. Witt M. Noehringer L. Rogachev V. Jäger A. Kataeva O. Fröhlich R. Metz P. Angew. Chem. Int. Ed. 2013; 52: 11651
9c Xiong D. Zhou W. Lu Z. Zeng S. Wang J. Chem. Commun. 2017; 53: 6844

10a Feng H. Jeffriesa M. Gravesa B. Grahama S. Pollarda D. Pang G. Chen H. Tetrahedron 2017; 73: 5745
10b Meng L. Jin MY. Wang J. Org. Lett. 2016; 18: 4986

11 Brown MK. Degrado SJ. Hoveyda AH. Angew. Chem. Int. Ed. 2005; 44: 5306
12 Vila C. Hornillos V. Fañanásmastral M. Feringa BL. Chem. Commun. 2013; 49: 5933
13 Hayashi T. Yamamoto S. Tokunaga N. Angew. Chem. Int. Ed. 2005; 44: 4224
14 Copper-Catalyzed Asymmetric Synthesis . Alexakis A. Krause N. Woodward S. Wiley-VCH; Weinheim: 2014
15 General Procedure for the Addition of Methylmagnesium Bromide to ThiochromonesAn oven-dried vial fitted with a stirring bar was charged with [Cu(MeCN)₄]PF₆ (3.73 mg, 5 mol%) and (R,S)-PPF-P ^t Bu₂ (6.51 mg, 6 mol%) in DCM (4.0 mL) and the mixture was stirred at rt for 30 min. Then, thiochromone 1a (0.20 mmol) was added and the mixture was then stirred at –75 °C for another 10 min. MeMgBr (0.30 mL, 0.30 mmol, 1.5 equiv; 1 M solution in THF) and iodotrimethylsilane (85 μL, 0.6 mmol, 3.0 equiv) were simultaneously added dropwise to the vial and the resulting mixture was stirred at –75 °C until the reaction was completed. The reaction was quenched with HCl aq (10%) and the mixture was stirred for 30 min at rt. Then, it was extracted with EtOAc and the organic layer was collected and concentrated under vacuum. The residue was purified by chromatography on silica gel (EtOAc/n-pentane 1:80) to obtain the desired products.6-Methoxy-2-methylthiochroman-4-one (3ba)Yellow liquid (29.8 mg, 72% yield). [α]_D ²⁵ = –59.320 (c 1.00, CH₂Cl₂). ee was determined to be 85% by HPLC analysis with a Chiralcel OJ-3 column (hexane/2-propanol 99.5:0.5, 1.0 mL/min, 254 nm); t _r (minor) = 36.8 min, t _r (major) = 44.6 min. ¹H NMR (400 MHz, CDCl₃): δ = 7.62 (d, J = 2.9 Hz, 1 H), 7.18 (d, J = 8.7 Hz, 1 H), 7.03 (dd, J = 8.7, 2.9 Hz, 1 H), 3.84 (s, 3 H), 3.62 (dqd, J = 13.7, 6.8, 3.1 Hz, 1 H), 3.02 (dd, J = 16.6, 3.0 Hz, 1 H), 2.76 (dd, J = 16.5, 11.6 Hz, 1 H), 1.44 (d, J = 6.8 Hz, 3 H) ppm. ¹³C NMR (100 MHz, CDCl₃): δ = 194.69, 157.40, 133.23, 131.16, 128.79, 122.50, 111.15, 55.57, 48.00, 36.68, 20.37 ppm. HRMS (ESI-ion trap): m/z: [M + H]⁺ calcd for C₁₁H₁₃O₂S: 209.0631; found: 209.0627.6-fluoro-2-methylthiochroman-4-one (3ia)Yellow liquid (38 mg, 96% yield). [α]_D ²⁵ = –85.050 (c 1.00, CH₂Cl₂). ee was determined to be 73% by HPLC analysis with a Chiralcel OJ-3 column (hexane/2-propanol 97:3, 1.0 mL/min, 254 nm); t _r (minor) = 9.0 min, t _r (major) = 9.8 min. ¹H NMR (400 MHz, CDCl₃): δ = 7.78 (dd, J = 9.3, 2.9 Hz, 1 H), 7.24 (dd, J = 8.7, 5.0 Hz, 1 H), 7.14 (ddd, J = 8.7, 7.8, 2.9 Hz, 1 H), 3.72–3.56 (m, 1 H), 3.02 (dd, J = 16.6, 3.0 Hz, 1 H), 2.75 (dd, J = 16.6, 11.6 Hz, 1 H), 1.44 (d, J = 6.8 Hz, 3 H) ppm. ¹³C NMR (100 MHz, CDCl₃): δ = 193.82, 160.62 (d, J = 244 Hz), 137.10 (d, J = 3.0 Hz), 131.90 (d, J = 5.8 Hz), 129.39 (d, J = 6.9 Hz), 121.52 (d, J = 23 Hz), 115.13 (d, J = 22 Hz), 47.68, 36.76 20.44 ppm. HRMS (ESI-ion trap): m/z: [M + H]⁺ calcd for C₁₀H₁₀OFS: 197.0431; found: 197.0424.

Supplementary Material

Supporting Information (PDF) (opens in new window)